erlotinib   Click here for help

GtoPdb Ligand ID: 4920

Synonyms: NSC 718781 | OSI 744 | OSI-774 | R 1415 | Tarceva®
Approved drug PDB Ligand
erlotinib is an approved drug (FDA (2004), EMA (2005))
Compound class: Synthetic organic
Comment: Erlotinib is a clinically approved type-1 inhibitor of the epidermal growth factor receptor (EGFR) receptor tyrosine kinase. This drug shows some selectivity for EGFR exon 19 deletion or exon 21 L858R mutations over the wild type receptor.
Subsequent studies have shown erlotinib to be a potent inhibitor of JAK2V617F activity. JAK2V617F, a mutant from of tyrosine kinase JAK2, is found in most patients with polycythemia vera (PV) and a substantial proportion of patients with idiopathic myelofibrosis or essential thrombocythemia. Study suggests that erlotinib may be used for treatment of JAK2V617F-positive PV and other myeloproliferative disorders. Specificity of inhibition with regard to other tyrosine kinase receptors remains to be fully characterized. Erlotinib is a Type-1 kinase inhibitor.
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: erlotinib

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 10
Topological polar surface area 74.73
Molecular weight 393.17
XLogP 2.7
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES COCCOc1cc2c(ncnc2cc1OCCOC)Nc1cccc(c1)C#C
Isomeric SMILES COCCOc1cc2c(ncnc2cc1OCCOC)Nc1cccc(c1)C#C
InChI InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)
Classification Click here for help
Compound class Synthetic organic
Approved drug? Yes (FDA (2004), EMA (2005))
WHO Essential Medicine WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version.
Click to view more information about the WHO Model Lists of Essential Medicines.
IUPAC Name Click here for help
International Nonproprietary Names Click here for help
INN number INN
8133 erlotinib
Synonyms Click here for help
NSC 718781 | OSI 744 | OSI-774 | R 1415 | Tarceva®
Database Links Click here for help
Specialist databases
Reactome Drug Reactome logo R-ALL-1173285
Reactome Reaction Reactome logo R-HSA-1220610
Other databases
CAS Registry No. 183321-74-6
ChEBI CHEBI:114785
DrugBank Ligand DB00530
DrugCentral Ligand 1045
GtoPdb PubChem SID 178101619
PubChem CID 176870
Search Google for chemical match using the InChIKey AAKJLRGGTJKAMG-UHFFFAOYSA-N
Search Google for chemicals with the same backbone AAKJLRGGTJKAMG
Search PubMed clinical trials erlotinib
Search PubMed titles erlotinib
Search PubMed titles/abstracts erlotinib
SynPHARM 81179 (in complex with epidermal growth factor receptor)
79526 (in complex with epidermal growth factor receptor)
UniChem Compound Search for chemical match using the InChIKey AAKJLRGGTJKAMG-UHFFFAOYSA-N
UniChem Connectivity Search for chemical match using the InChIKey AAKJLRGGTJKAMG-UHFFFAOYSA-N
Wikipedia Erlotinib